Swiss National Bank Increases Stake in Keros Therapeutics, Inc. (NASDAQ:KROS)

Swiss National Bank lifted its stake in shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 4.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,600 shares of the company’s stock after buying an additional 2,100 shares during the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Sienna Senior Living (TSE:SIA) Given New C$14.00 Price Target at Royal Bank of Canada
Next post Swiss National Bank Boosts Stake in Dynex Capital, Inc. (NYSE:DX)